128 related articles for article (PubMed ID: 28733954)
1. Assessment of simplified ratio-based approaches for quantification of PET [
Matheson GJ; Plavén-Sigray P; Forsberg A; Varrone A; Farde L; Cervenka S
EJNMMI Res; 2017 Dec; 7(1):58. PubMed ID: 28733954
[TBL] [Abstract][Full Text] [Related]
2. Cerebellum Can Serve As a Pseudo-Reference Region in Alzheimer Disease to Detect Neuroinflammation Measured with PET Radioligand Binding to Translocator Protein.
Lyoo CH; Ikawa M; Liow JS; Zoghbi SS; Morse CL; Pike VW; Fujita M; Innis RB; Kreisl WC
J Nucl Med; 2015 May; 56(5):701-6. PubMed ID: 25766898
[TBL] [Abstract][Full Text] [Related]
3. Comparison of standardized uptake values with volume of distribution for quantitation of [(11)C]PBR28 brain uptake.
Yoder KK; Territo PR; Hutchins GD; Hannestad J; Morris ED; Gallezot JD; Normandin MD; Cosgrove KP
Nucl Med Biol; 2015 Mar; 42(3):305-8. PubMed ID: 25487553
[TBL] [Abstract][Full Text] [Related]
4. Moving Toward Multicenter Therapeutic Trials in Amyotrophic Lateral Sclerosis: Feasibility of Data Pooling Using Different Translocator Protein PET Radioligands.
Van Weehaeghe D; Babu S; De Vocht J; Zürcher NR; Chew S; Tseng CJ; Loggia ML; Koole M; Rezaei A; Schramm G; Van Damme P; Hooker JM; Van Laere K; Atassi N
J Nucl Med; 2020 Nov; 61(11):1621-1627. PubMed ID: 32169920
[TBL] [Abstract][Full Text] [Related]
5. Pseudoreference Regions for Glial Imaging with
Albrecht DS; Normandin MD; Shcherbinin S; Wooten DW; Schwarz AJ; Zürcher NR; Barth VN; Guehl NJ; Akeju O; Atassi N; Veronese M; Turkheimer F; Hooker JM; Loggia ML
J Nucl Med; 2018 Jan; 59(1):107-114. PubMed ID: 28818984
[TBL] [Abstract][Full Text] [Related]
6. Positron Emission Tomography studies with [11C]PBR28 in the Healthy Rodent Brain: Validating SUV as an Outcome Measure of Neuroinflammation.
Tóth M; Doorduin J; Häggkvist J; Varrone A; Amini N; Halldin C; Gulyás B
PLoS One; 2015; 10(5):e0125917. PubMed ID: 25996996
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic Evaluation of the Tau PET Radiotracer
Wooten DW; Guehl NJ; Verwer EE; Shoup TM; Yokell DL; Zubcevik N; Vasdev N; Zafonte RD; Johnson KA; El Fakhri G; Normandin MD
J Nucl Med; 2017 Mar; 58(3):484-491. PubMed ID: 27660144
[No Abstract] [Full Text] [Related]
8. Quantification of O-(2-[
Koopman T; Verburg N; Schuit RC; Pouwels PJW; Wesseling P; Windhorst AD; Hoekstra OS; de Witt Hamer PC; Lammertsma AA; Boellaard R; Yaqub M
EJNMMI Res; 2018 Jul; 8(1):72. PubMed ID: 30066053
[TBL] [Abstract][Full Text] [Related]
9. Test-retest analysis of a non-invasive method of quantifying [(11)C]-PBR28 binding in Alzheimer's disease.
Nair A; Veronese M; Xu X; Curtis C; Turkheimer F; Howard R; Reeves S
EJNMMI Res; 2016 Dec; 6(1):72. PubMed ID: 27678494
[TBL] [Abstract][Full Text] [Related]
10. Tracer Kinetic Analysis of (S)-¹⁸F-THK5117 as a PET Tracer for Assessing Tau Pathology.
Jonasson M; Wall A; Chiotis K; Saint-Aubert L; Wilking H; Sprycha M; Borg B; Thibblin A; Eriksson J; Sörensen J; Antoni G; Nordberg A; Lubberink M
J Nucl Med; 2016 Apr; 57(4):574-81. PubMed ID: 26795290
[TBL] [Abstract][Full Text] [Related]
11. PET quantification of 18F-florbetaben binding to β-amyloid deposits in human brains.
Becker GA; Ichise M; Barthel H; Luthardt J; Patt M; Seese A; Schultze-Mosgau M; Rohde B; Gertz HJ; Reininger C; Sabri O
J Nucl Med; 2013 May; 54(5):723-31. PubMed ID: 23471310
[TBL] [Abstract][Full Text] [Related]
12. In vivo TSPO imaging in patients with multiple sclerosis: a brain PET study with [18F]FEDAA1106.
Takano A; Piehl F; Hillert J; Varrone A; Nag S; Gulyás B; Stenkrona P; Villemagne VL; Rowe CC; Macdonell R; Tawil NA; Kucinski T; Zimmermann T; Schultze-Mosgau M; Thiele A; Hoffmann A; Halldin C
EJNMMI Res; 2013 Apr; 3(1):30. PubMed ID: 23618062
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Invasive and Non-invasive Estimation of [
Aceves-Serrano L; Sossi V; Doudet DJ
Mol Imaging Biol; 2022 Jun; 24(3):404-415. PubMed ID: 34622422
[TBL] [Abstract][Full Text] [Related]
14. Accuracy and reliability of [
Plavén-Sigray P; Schain M; Zanderigo F; ; Rabiner EA; Gunn RN; Ogden RT; Cervenka S
Neuroimage; 2019 Mar; 188():102-110. PubMed ID: 30500425
[TBL] [Abstract][Full Text] [Related]
15. Brain translocator protein occupancy by ONO-2952 in healthy adults: A Phase 1 PET study using [
Frankle WG; Narendran R; Wood AT; Suto F; Himes ML; Kobayashi M; Ohno T; Yamauchi A; Mitsui K; Duffy K; Bruce M
Synapse; 2017 Jul; 71(7):. PubMed ID: 28245513
[TBL] [Abstract][Full Text] [Related]
16. Validation of the Semiquantitative Static SUVR Method for
Ottoy J; Verhaeghe J; Niemantsverdriet E; Wyffels L; Somers C; De Roeck E; Struyfs H; Soetewey F; Deleye S; Van den Bossche T; Van Mossevelde S; Ceyssens S; Versijpt J; Stroobants S; Engelborghs S; Staelens S
J Nucl Med; 2017 Sep; 58(9):1483-1489. PubMed ID: 28336779
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous assessment of blood flow and myelin content in the brain white matter with dynamic [11 C]PiB PET: a test-retest study in healthy controls.
Yazdan-Panah A; Bodini B; Soulier T; Veronese M; Bottlaender M; Tonietto M; Stankoff B
EJNMMI Res; 2024 May; 14(1):50. PubMed ID: 38801594
[TBL] [Abstract][Full Text] [Related]
18. Test-retest reproducibility of cerebral adenosine A
Toyohara J; Sakata M; Wagatsuma K; Tago T; Ishibashi K; Ishii K; Elsinga P; Ishiwata K
Ann Nucl Med; 2022 Jan; 36(1):15-23. PubMed ID: 34564828
[TBL] [Abstract][Full Text] [Related]
19.
Ottoy J; De Picker L; Verhaeghe J; Deleye S; Wyffels L; Kosten L; Sabbe B; Coppens V; Timmers M; van Nueten L; Ceyssens S; Stroobants S; Morrens M; Staelens S
J Nucl Med; 2018 Aug; 59(8):1267-1274. PubMed ID: 29326362
[TBL] [Abstract][Full Text] [Related]
20. Test-retest reproducibility of [(11)C]PBR28 binding to TSPO in healthy control subjects.
Collste K; Forsberg A; Varrone A; Amini N; Aeinehband S; Yakushev I; Halldin C; Farde L; Cervenka S
Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):173-183. PubMed ID: 26293827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
